EFFECT OF SUBCUTANEOUS RECOMBINANT HUMAN ERYTHROPOIETIN ON BLOOD PRESSURE IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) PATIENTS
Objective: To determine the effect of subcutaneous recombinant human erythropoietin on blood pressure in pre-dialysis chronic kidney disease (CKD) patients. Study Design: Case-series descriptive study. Place and Duration of Study: Combined Military Hospital Peshawar, from Mar 2016 to Sep 2016. Metho...
Saved in:
Main Authors: | Muhammad Sajid Hussain, Qasim Raza, Muhammad Omer Aamir, Nadia Murtaza, Sadia Naureen, Mehwish Razzaq |
---|---|
Format: | article |
Language: | EN |
Published: |
Army Medical College Rawalpindi
2021
|
Subjects: | |
Online Access: | https://doi.org/10.51253/pafmj.v71i1.2489 https://doaj.org/article/200da42cfcd8473eb242201c91a2c6b5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS
by: V. D. Nazarov, et al.
Published: (2018) -
Comparative effectiveness of erythropoietin alpha and beta in hemodialysis patients: a single-center prospective observational study
by: Muhammad Nadeem Ahsan, et al.
Published: (2021) -
PCR assembly of synthetic human erythropoietin gene
by: Bustami,Yazmin, et al.
Published: (2009) -
Characteristics of erythropoietin antibodies in patients treated with recombinant human erythropoietin
by: A. M. Kudryashova, et al.
Published: (2020) -
Serum Erythropoietin level in children with different degrees of chronic renal failure
by: Gh Al-Hosseini Hashemi, et al.
Published: (2000)